Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParity Regulatory News (PTY)

Share Price Information for Parity (PTY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.925
Bid: 0.85
Ask: 1.00
Change: 0.00 (0.00%)
Spread: 0.15 (17.647%)
Open: 0.925
High: 0.925
Low: 0.925
Prev. Close: 0.925
PTY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jan 2023 07:00

RNS Number : 8904N
Parity Group PLC
26 January 2023
 

Parity Group plc  

("Parity" or the "Company") 

 

Trading Update

 

 

 

Parity Group plc (AIM: PTY), the data and technology-focused recruitment and professional services company, is pleased to issue a trading update for the financial year ended 31 December 2022 ("FY2022").

FY2022 Highlights

The board is pleased to report a significantly improved operating performance despite the expected reduction in net fee income during the year.

· Net Fee Income for FY2022 expected to be £3.5m compared to £4.1m in FY2021.

· Adjusted EBITDA(1) for FY2022 expected to be circa £0.4m vs £0.1m in the prior year.

· Significant improvement in operating performance in FY2022 with anticipated break even at Adjusted Operating profit (2) level compared to a £0.3m loss in the prior year.

· Other income in FY2022 of £1m from the sale and licence back of the Parity trademarks in the UK and EU.

· Profit before Tax for FY2022 expected to be £0.5m vs loss of £1.1m in the prior year.

 

During FY2022, Parity has refocused its business around recruitment, increasing customer-facing headcount and establishing an efficient operating model. This has enabled the business to significantly improve profitability during the period, and with the sale and licence back of the trademark, to deliver a profit before tax which we expect to be £0.5m.

The income from the trademark sale and licence back will enable Parity to invest further in customer-facing roles to generate new business and leverage the operating model of the business.

 

Mark Braund, Executive Chairman, said:

"We have successfully transitioned the business to focus on the core commercial recruitment capability of Parity. As we look forward, Parity is a more agile, albeit smaller business with a strong work culture and a much-improved focus on what we are 'great' at.

"This foundation, along with the additional funding from the sale of the trademark, creates a solid base from which we can continue to evolve the business. Whilst the outlook for the wider economy is becoming less certain, our strength in providing skilled technology resources to support the almost relentless demand for digital transformation services, places Parity in a reassuringly solid position. We aim to take advantage of the platform we have established to invest carefully in relevant new areas of business that will support longer-term sustainable profit and growth. 

"The enthusiasm, commitment and tenacity of all my colleagues is at the core of Parity's turnaround. For this and on behalf of the Board, we say a heartfelt "thank you".

"We remain focused on maintaining our positive momentum and positioning the business for further growth."

(1) Adjusted EBITDA is defined as operating profit before finance costs, tax, depreciation, amortisation and non-underlying items.

(2) Adjusted Operating profit is defined as operating profit before finance costs and non-underlying items.

 

Contacts

Parity Group plc

Tel: + 44 (0) 20 8171 1729

Mark Braund, Executive Chairman

www.parity.net

Mike Johns, Chief Financial Officer

Allenby Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0) 20 3328 5656

David Hart / Dan Dearden-Williams (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBAMPTMTTTBJJ
Date   Source Headline
11th Aug 20207:00 amRNSPartnership with CyberGym
20th Jul 20207:00 amRNSTrading Update
17th Jun 20207:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:54 amRNSResult of AGM
10th Jun 20208:54 amRNSDirector/PDMR Shareholding
8th Jun 20207:00 amRNSDirectorate Change
27th May 202011:33 amRNSHolding(s) in Company
19th May 202010:59 amRNSNotice of AGM and Posting of Accounts
11th May 202011:07 amRNSHolding(s) in Company
29th Apr 20209:27 amRNSDirectorate Change
24th Apr 20207:00 amRNSGrant of Options
16th Apr 20207:00 amRNSFinal Results
14th Apr 202010:12 amRNSNotice of Results
31st Mar 20207:00 amRNSTrading Statement
21st Jan 20207:00 amRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update
19th Dec 20199:50 amRNSFramework Agreement
19th Nov 20197:00 amRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSHoT regarding revenue share on AI data platform
26th Sep 20194:52 pmRNSGrant of Options
20th Sep 20197:00 amRNSHalf-year Report
22nd Aug 20197:00 amRNSHolding(s) in Company
19th Aug 20194:38 pmRNSHolding(s) in Company
30th Jul 20197:00 amRNSNotice of Interim Results
11th Jul 20199:56 amRNSHolding(s) in Company
13th Jun 20195:53 pmRNSDirector Disclosures
30th May 201911:59 amRNSResult of AGM
20th May 20193:32 pmRNSHolding(s) in Company
8th May 20197:00 amRNSPosting of Accounts
18th Apr 201911:37 amRNSDirector/PDMR Shareholding
17th Apr 201910:36 amRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSSenior Management Appointment
16th Apr 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSDirectorate Change
29th Mar 20197:00 amRNSTrading Update
1st Mar 201911:50 amRNSHolding(s) in Company
26th Feb 20197:00 amRNSContract
25th Feb 20198:11 amRNSBlock listing Interim Review
20th Feb 20191:38 pmRNSHolding(s) in Company
8th Feb 201910:32 amRNSHolding(s) in Company
5th Feb 20199:30 amRNSTrading Statement
8th Nov 20187:00 amRNSDirector/PDMR Shareholding
7th Nov 20187:00 amRNSDirector/PDMR Shareholding
2nd Nov 20184:02 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSTrading Update
10th Oct 20189:09 amRNSHolding(s) in Company
3rd Oct 20184:42 pmRNSHolding(s) in Company
26th Sep 20185:11 pmRNSHolding(s) in Company
21st Sep 201811:06 amRNSHolding(s) in Company
20th Sep 20187:00 amRNSUnaduited financial report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.